Rational sequence of monoclonal antibodies in the treatment of non-resectable head and neck squamous cell carcinoma
This article discusses current approaches to first-line chemotherapy for non-resectable head and neck squamous cell carcinoma and describes factors affecting the choice of treatment regimen according to the results of randomized clinical trials. We provide a rationale for creating a long-term strate...
Main Authors: | L. V. Bolotina, T. V. Ustinova, T. I. Dеshkina, P. V. Golubev, N. N. Lyubavina, A. A. Fedenko, A. D. Kaprin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-04-01
|
Series: | Опухоли головы и шеи |
Subjects: | |
Online Access: | https://ogsh.abvpress.ru/jour/article/view/735 |
Similar Items
-
Primenenie tsetuksimaba v lechenii ploskokletochnogo raka golovy i shei
by: I S Romanov, et al.
Published: (2008-06-01) -
Induction chemotherapy with docetaxel and doxorubicin followed by proton beam radiation therapy for platinum-resistant unresectable sinonasal undifferentiated carcinoma
by: A. A. Kachmazov, et al.
Published: (2021-11-01) -
Choice of optimal therapeutic sequence in treatment of patients with progressive / metastatic squamous cell cancer of the head and neck in the light of TPEx study results
by: A. M. Mudunov
Published: (2022-02-01) -
NIVOLUMAB IN THE TREATMENT OF REFRACTORY RECURRENT AND METАSTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA. THE RESULTS OF A PHASE III CLINICAL TRIAL (CHECKMATE 141)
by: A. M. Mudunov
Published: (2017-11-01) -
VARIABILITY AND microRNA EXPRESSION LEVEL IN TISSUES OF HEAD AND NECK TUMORS
by: Е. G. Nikitina, et al.
Published: (2016-02-01)